drugset / Trial / NCT00714584

Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers

NCT00714584

Phase 1 Completed 18 enrolled Alza Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare the pharmacokinetics of naltrexone following i.v. and oral administration in healthy volunteers, and to assess the bioavailability of naltrexone following oral administration. Moreover, safety is assessed.

Timeline

Start
2003-05
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 1 mg Intravenous
Subject Naltrexone Small molecule 50 mg Intravenous

Indications

No indication recorded.